Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 6;8(3):30.
doi: 10.3390/diseases8030030.

"Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies

Affiliations
Review

"Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies

Partha Laskar et al. Diseases. .

Abstract

The outbreak of novel coronavirus disease (2019-nCoV or COVID-19) is responsible for severe health emergency throughout the world. The attack of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is found to be responsible for COVID-19. The World Health Organization has declared the ongoing global public health emergency as a pandemic. The whole world fights against this invincible enemy in various capacities to restore economy, lifestyle, and safe life. Enormous amount of scientific research work(s), administrative strategies, and economic measurements are in place to create a successful step against COVID-19. Furthermore, differences in opinion, facts, and implementation methods laid additional layers of complexities in this battle against survival. Thus, a timely overview of the recent, important, and overall inclusive developments against this pandemic is a pressing need for better understanding and dealing with COVID-19. In this review, we have systematically summarized the epidemiological studies, clinical features, biological properties, diagnostic methods, treatment modalities, and preventive measurements related to COVID-19.

Keywords: COVID-19; alternatives; biology; controversies; coronavirus; data; diagnosis; prevention; technology; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Distribution of COVID-19 cases over various continents according to Worldometer (data accessed on 24th July, 2020). (B) Year-wise results for research on “Coronavirus” and “Coronavirus Disease” keyword for last 10 years (2020–2011) according to PubMed (data accessed on 24th July, 2020).
Figure 2
Figure 2
Hypothetical cartoon presentation of morphology, structural constituents, and possible receptor mediated cellular binding of SARS-CoV-2. Size, shape, and integral components are for visualization purpose only and do not exactly replicate the ultra-structural morphology of virus.
Figure 3
Figure 3
Possible treatment modalities against COVID-19.
Figure 4
Figure 4
Four most promising drug candidates or combinations approved for clinical trial for COVID-19 treatment by WHO (announced on 18 March 2020).
Figure 5
Figure 5
Three primary modes of preventive strategies to manage COVID-19 pandemic.
Figure 6
Figure 6
Possible preventive methodologies against infectious disease in future.

Similar articles

Cited by

References

    1. McIntosh K. Coronaviruses: A Comparative Review. Volume 63 Springer; Berlin/Heidelberg, Germany: 1974.
    1. Contini C., Di Nuzzo M., Barp N., Bonazza A., De Giorgio R., Tognon M., Rubino S. The novel zoonotic COVID-19 pandemic: An expected global health concern. J. Infect. Dev. Ctries. 2020;14:254–264. doi: 10.3855/jidc.12671. - DOI - PubMed
    1. Schoeman D., Fielding B.C. Coronavirus envelope protein: Current knowledge. Virol. J. 2019;16:69. doi: 10.1186/s12985-019-1182-0. - DOI - PMC - PubMed
    1. McIntosh K., Peiris J.S.M. Clinical Virology. 3rd ed. ASM Press; Washington, DC, USA: 2009. Coronaviruses; pp. 1155–1171. - DOI
    1. Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181:281.e286–292.e286. doi: 10.1016/j.cell.2020.02.058. - DOI - PMC - PubMed

LinkOut - more resources